Table 3.
Proportion of participants with a clinically significant level of mental distress, by year*
| 2014–15 (n=26 979) | 2015–16 (n=44 024) | 2016–17 (n=39 984) | 2017–18 (n=33 540) | 2018–19 (n=12 312) | April, 2020 (n=17 452) | ||
|---|---|---|---|---|---|---|---|
| Overall | 16·7% (16·1–17·3) | 16·9% (16·4–17·4) | 18·2% (17·7–18·8) | 19·0% (18·4–19·6) | 18·9% (17·8–20·0) | 27·3% (26·3–28·2) | |
| Gender | |||||||
| Women | 19·4% (18·7–20·2) | 19·8% (19·1–20·5) | 21·0% (20·3–21·7) | 22·4% (21·6–23·3) | 23·0% (21·5–24·5) | 33·3% (32·0–34·6) | |
| Men | 13·7% (12·9–14·5) | 13·8% (13·1–14·4) | 15·2% (14·5–15·9) | 15·3% (14·5–16·1) | 14·5% (13·0–16·0) | 20·4% (19·1–21·7) | |
| Age, years | |||||||
| 16–24 | 19·8% (18·0–21·6) | 19·6% (18·2–21·0) | 19·7% (18·2–21·3) | 23·5% (21·7–25·3) | 24·5% (21·3–27·8) | 36·7% (32·9–40·5) | |
| 25–34 | 18·1% (16·4–19·8) | 18·3% (16·8–19·7) | 20·5% (18·9–22·2) | 21·7% (19·7–23·6) | 21·6% (18·1–25·1) | 35·0% (31·9–38·2) | |
| 35–44 | 18·3% (16·8–19·8) | 18·1% (16·9–19·4) | 19·2% (17·9–20·5) | 19·9% (18·3–21·5) | 21·0% (18·4–23·7) | 30·6% (28·2–33·0) | |
| 45–54 | 18·3% (17·0–19·6) | 18·8% (17·7–19·9) | 20·0% (18·8–21·2) | 20·5% (19·1–21·9) | 21·5% (18·9–24·0) | 26·3% (24·3–28·2) | |
| 55–69 | 14·8% (13·8–15·8) | 15·2% (14·3–16·1) | 16·5% (15·6–17·5) | 17·7% (16·6–18·8) | 17·0% (15·1–18·8) | 24·7% (23·2–26·3) | |
| ≥70 | 12·9% (11·7–14·1) | 12·8% (11·8–13·8) | 14·6% (13·5–15·7) | 12·9% (11·8–14·0) | 10·8% (9·1–12·4) | 17·6% (15·7–19·5) | |
Data are proportion of participants with a clinically significant level of mental distress (95% CI). 53 314 total participants. Sample sizes are true (unweighted). All analyses are weighted, adjusting for complex survey design and non-response.
*
Based on financial year, from April to March.